1. Home
  2. VEEA vs CGEN Comparison

VEEA vs CGEN Comparison

Compare VEEA & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEA
  • CGEN
  • Stock Information
  • Founded
  • VEEA 2014
  • CGEN 1993
  • Country
  • VEEA United States
  • CGEN Israel
  • Employees
  • VEEA N/A
  • CGEN N/A
  • Industry
  • VEEA
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VEEA
  • CGEN Health Care
  • Exchange
  • VEEA NYSE
  • CGEN Nasdaq
  • Market Cap
  • VEEA 112.2M
  • CGEN 117.8M
  • IPO Year
  • VEEA N/A
  • CGEN 2000
  • Fundamental
  • Price
  • VEEA $2.07
  • CGEN $1.50
  • Analyst Decision
  • VEEA
  • CGEN
  • Analyst Count
  • VEEA 0
  • CGEN 0
  • Target Price
  • VEEA N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • VEEA 46.5K
  • CGEN 216.3K
  • Earning Date
  • VEEA 06-10-2025
  • CGEN 05-19-2025
  • Dividend Yield
  • VEEA N/A
  • CGEN N/A
  • EPS Growth
  • VEEA N/A
  • CGEN N/A
  • EPS
  • VEEA N/A
  • CGEN N/A
  • Revenue
  • VEEA $139,252.00
  • CGEN $27,589,000.00
  • Revenue This Year
  • VEEA N/A
  • CGEN $11.81
  • Revenue Next Year
  • VEEA N/A
  • CGEN $28.37
  • P/E Ratio
  • VEEA N/A
  • CGEN N/A
  • Revenue Growth
  • VEEA N/A
  • CGEN N/A
  • 52 Week Low
  • VEEA $1.33
  • CGEN $1.13
  • 52 Week High
  • VEEA $18.56
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • VEEA N/A
  • CGEN 56.17
  • Support Level
  • VEEA N/A
  • CGEN $1.38
  • Resistance Level
  • VEEA N/A
  • CGEN $1.56
  • Average True Range (ATR)
  • VEEA 0.00
  • CGEN 0.08
  • MACD
  • VEEA 0.00
  • CGEN 0.02
  • Stochastic Oscillator
  • VEEA 0.00
  • CGEN 77.78

About VEEA VEEA INC

Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: